L uminal narrowing after percutaneous transluminal coronary angioplasty (PTCA) is a complex process that is only partially understood. Histological studies of coronary arteries after dilation, obtained by either autopsy or atherectomy, have provided evidence that strongly supports the concept of intimal hyperplasia or proliferation of smooth muscle cells of medial or intimal origin as the underlying cause of luminal narrowing after angioplasty.1-3 Pharmacological agents aimed at reducing the absolute amount of intimal hyperplasia are currently being investigated in many clinical trials. In these trials, it is presumed that the clinical outcome is related to an anatomic substrate, ie, the prevention or reduction of reactive intimal hyperplasia after angioplasty.
If restenosis is viewed as an intraluminal growth process after a successful angioplasty, risk factors for restenosis should be risk factors for this growth process. The angiographically determined change in lumen diameter at follow-up is currently the only reliable indicator of the amount of reactive hyperplasia applicable to large study populations.
A model that accurately predicts the amount of luminal narrowing in the individual patient would be of value in several ways: First, it could be an aid in patient or lesion selection for the procedure because an accumulation of risk factors in the individual patient might indicate balloon angioplasty as an unattractive means of revascularization; second, it could improve assessment of medium-term (6 months) prognosis in the individual patient; third, modification or control of the identified risk factors could reduce overall restenosis rates; fourth, the model could assist in the selection of patients at risk for a large loss in lumen diameter. This population could then constitute the target population for pharmacological intervention studies because a larger mean loss in lumen diameter would permit the enrollment of a smaller number of patients in a study while maintaining an equal power. Therefore, patient-related factors, lesion-related factors, and procedural factors were correlated to the quantitative angiographic change in lumen diameter from postangioplasty angiogram to follow-up angiogram in the present study.
Methods

Study Population
The study population consisted of 697 patients that were originally randomized in six European centers (see "Appendix") for the CARPORT Trial. 4 In this randomized double-blind, placebo-controlled trial, a novel thromboxane A2 receptor antagonist (GR32191B) was investigated for its ability to prevent the restenosis process after primary coronary angioplasty. Follow-up on these patients was done on a prospective basis, and all patients agreed to undergo repeat angiography at 6 months. Identical angiographic and clinical outcomes were observed,4 so the placebo-treated and active treatment group were pooled for the present study. All patients with both stable and unstable angina and angiographically proven native coronary artery disease who were scheduled for primary angioplasty were considered for inclusion. Exclusion criteria for trial participation and their relative frequencies have been published earlier. 4 Angioplasty success was defined as a <50% residual stenosis by visual inspection of the postangioplasty angiogram and no occurrence of in-hospital complications (death, acute myocardial infarction, repeat angioplasty, aortocoronary bypass grafting, or recurrence of symptoms) and was achieved in 649 patients (93.1%). Quantitative angiographic follow-up was available for 575 patients (88.6%), and this forms the study population (Fig 1) . Angioplasty Procedure and Follow-up Angiography
Coronary angioplasty was performed with a steerable, movable guide wire system via the femoral route.
Standard available balloon catheters were used. Choice of balloon type and brand as well as inflation duration and inflation pressure were left to the discretion of the angioplasty operator. At the beginning of the angioplasty procedure, all patients received 10000 IU of intravenous heparin for the first 2 hours and afterward, 5000 lU/h for as long as the procedure continued. All patients received 10 mg nifedipine every 2 hours for the first 12 hours after angioplasty. Thereafter, they received 20 mg slow-release nifedipine tablets three times during the second day after angioplasty.
Three coronary angiograms were obtained in each patient just before angioplasty, immediately after angioplasty, and at follow-up. To standardize the method of data acquisition and to ensure exact reproducibility of the angiographic studies, measurements were taken as described previously.5-7 The angiograms were recorded in such a way that they were suited for quantitative analysis by the Coronary Angiography Analysis System (CAAS). All necessary details of the procedure were recorded, and drawings of the segments to be analyzed were made. For calibration purposes, the catheter tips were cut off for later measurement with a microcaliper. All angiograms were processed and analyzed in a central core laboratory. At least two views of all lesions were analyzed-orthogonal if possible. A difference in angulation of at least 300 was required for a view to be separately analyzed.
The follow-up coronary angiogram was performed at 6 months. If symptoms recurred within 6 months, coronary angiography was carried out earlier. If no definite restenosis was present and no revascularization procedure was performed and the follow-up time was less than 4 months, the patient was asked to undergo another coronary arteriogram at 6 months. Quantitative Angiography All cineangiograms were analyzed using the computer-assisted angiography analysis system (CAAS), which has been described and validated previously.8,9 A computer-derived reconstruction of the original arterial dimension at the site of obstruction (assuming there is no disease present) is used to define the interpolated reference diameter. The area between the actual and reconstructed contours at the obstruction site is a measurement for the amount of atherosclerotic plaque and is expressed in millimeters squared. The length of the obstruction is determined from the diameter function on the basis of curvature analysis and is expressed in millimeters. In addition, this technique allows for the calculation of an eccentricity index of the lesion.10 The index ranges from 0 (severe eccentric) to 1 (perfectly symmetrical). Since the analysis system cannot measure total occlusions, a value of 0 mm was substituted for the minimal lumen diameter, and the postangioplasty ref- erence Procedure-related factors assessed were maximal measured balloon diameter, balloon-artery ratio (defined as the ratio of the quantitative angiographic diameter of the largest balloon at highest inflation pressure to the reference diameter), maximal inflation pressure, number of balloon inflations, and total duration of balloon inflation.
Data Analysis
The unit of analysis reported here is the stenotic lesion, not the patient. The primary outcome variable was the change in lumen diameter from directly after angioplasty to follow-up angiogram. For the univariate analysis, continuous variables were divided into tertiles, and the three subgroups were compared with respect to absolute lumen change using an ANOVA. For the subgroups defined by binary variables, lumen change was compared using a Student's t test.
To obtain independent predictors for the loss in lumen diameter, variables were entered in a stepwise multiple linear A second multiple linear regression analysis on a per-patient basis was done to confirm the per-lesion results, which might be biased because of lack of independence among multiple dilated lesions in the same patients. In this analysis, only the lesion that narrowed the most was taken into consideration.
To determine how well the regression model performs in predicting the magnitude of the restenosis process according to two frequently applied restenosis criteria and to illustrate the discrepancies between the two criteria, receiver operator characteristic (ROC) curves were constructed for each criterion. The criteria applied were: change in lumen diameter .0.72 mm at follow-up-5812 and the classic criterion of an increase in diameter stenosis from <50% before PTCA to .50% at follow-up. The 0.72-mm value takes into account the limitations of coronary angiographic measurements and represents twice the long-term variability for repeat measurements of a coronary obstruction using the CAAS system.8 The use of 1 SD would include 68.3% of the measurement variability, whereas the use of 2 SD (2x0.36=0.72 mm) includes 95.5% of the measurement variability. The equivalent of the 0.72-mm value for diameter stenosis measurements is a change in diameter stenosis of 13%. In these ROC curves, sensitivity (true positive %) at different cut-off points of predicted change in minimal lumen diameter is graphed as a function of 100% minus specificity (false-positive %).
Results
Of 649 patients who had a successful angioplasty, 575 underwent satisfactory angiographic follow-up (follow-up rate, 88.6%) and formed the study population. Baseline characteristics of the study population are summarized in Table 1 Lesion-related variables. The preangioplasty lesionrelated factors associated with a larger loss at follow-up were smaller minimal lumen diameter, lesion length .6.8 mm, higher percentage diameter stenosis, larger plaque area, total occlusion, and collateral circulation to the obstruction site ( Table 3 ). The postangioplasty lesion-related factors associated with a greater loss at follow-up were a larger postangioplasty lumen diameter, lower percentage diameter stenosis after angioplasty (ie, a better angioplasty result), a higher relative gain achieved at angioplasty, and thrombus after angioplasty. Again, if total occlusions at follow-up were disregarded, the presence of total occlusions before angioplasty, collateral circulation, and thrombus after angioplasty were no longer associated with a significantly higher loss in minimal lumen diameter (total occlusion, -0.11±0. Procedure-related variables. None of the procedural factors assessed was associated with a significantly greater loss in lumen diameter at follow-up (Table 4) .
Multiple Linear Regression Analysis
The stepwise multiple linear regression analysis showed two preangioplasty angiographic characteristics as predictive of luminal narrowing at follow-up, namely, length of the stenosis and the minimal lumen diameter score the poor predictability of luminal narrowing and restenosis after balloon angioplasty and explain the differences between the restenosis criteria.
In an attempt to do an analysis on a per-patient rather than on a per-lesion basis, the analysis was repeated. In case of multilesion dilatations, only the lesion that narrowed the most was considered for this analysis. In Table 6 , the results of this analysis are summarized. The same variables were retained with almost equal coefficients. Only a visible thrombus on the postangioplasty angiogram was not retained in the multiple linear regression analysis on a per-patient basis (F to enter was 3.6). Discussion During 15 years of percutaneous transluminal coronary balloon angioplasty, an abundance of clinical and experimental studies have been carried out in an attempt to elucidate factors that can predict the "Achilles' heel" of coronary angioplasty, namely progressive luminal narrowing after a successful procedure. Although many clinical, procedural, and lesion-related factors have been linked with a higher angiographic restenosis rate, results of these studies are sometimes conflicting. As pointed out by Beatt et al,13 most of the discrepancies can be attributed to (1) patient selection, (2) the method of analysis, and (3) the definition of angiographic restenosis used.
Patient Selection
To obtain objective, unbiased results, all patients should be recatheterized after a predetermined follow-up period regardless of their symptomatic status. Failure to perform angiographic follow-up in a majority of patients will introduce bias in the assessment of the true change in minimal lumen diameter at follow-up. The restenosis rate according to a more or less arbitrary cut-off point will be biased toward higher values if symptomatic patients or patients with unfavorable anatomy after angioplasty are preferentially recatheterized. In this study, 88.6% of all patients with a successful angioplasty had a follow-up angiogram performed within a predetermined time frame of 6 months.
Method ofAnalysis
A well-validated quantitative angiographic analysis system should be used. Computer-assisted automated edge detection techniques enhance objectivity and reproducibility and reduce the high interobserver and intraobserver variability inherent to visual interpreta-tion of the coronary angiogram.1415 The quantitative analysis system we applied for the analysis of the angiograms meets these requirements. 13 Recently we performed a study16 comparing luminal dimensions 24 hours after angioplasty with those on the immediate postangioplasty angiogram using the same methodology as in the present study. Mean difference in minimal lumen diameter (accuracy) of 119 lesions was 0.00 mm, with a standard deviation (precision) of 0.20 mm. It was concluded that (1) in the first 24 hours after angioplasty, no major renarrowing takes place, and (2) variability of the CAAS measurements immediately after balloon dilatation is less than the long-term variability of the method.8 It should be noted that this long-term variability was measured 8 years ago on stenoses not submitted to angioplasty and with a reference diameter of 3.6 mm (present study, 2.6 mm). Also, standardization of angiofilm recording was not performed in the CAAS variability study. 8 In that study, no attempt was made to standardize on technical characteristics of the x-ray gantry or on vasomotor tone (intracoronary injection of the same amount of nitrates before pre-PTCA, post-PTCA and follow-up angiography). We therefore feel that the long-term variability of the system under a strictly standardized angiography protocol is closer to 0.20 mm than the earlier reported 0.36 mm. However, even if a precision of 0.20 mm is regarded as correct in the setting of this study, part of the changes in lumen diameter fall within the measurement error of technique. This can be a possible reason for the poor fit of the multiple linear regression equation. Another point of concern with quantitative analysis of a lesion immediately after angioplasty is the amount of analyst interference with the automated edge detection technique. In our population, the amount of editing performed by the analysts was 3.7% before angioplasty, 4.2% after angioplasty, and 3.7% at follow-up angiography; that is, 4.2% of the automatically detected vessel contours were corrected by the analysts. The interobserver and intraobserver variability of the analysis of the postangioplasty angiogram is subject to ongoing investigation, and data are not yet available. We can therefore conclude that for quantitative analysis of the immediate postangioplasty angiogram, most likely the same variability values apply as for quantitative analysis of nondilated vessel segments.
Restenosis Criteria
The third factor influencing the restenosis rates is the restenosis criterion. The most frequently applied criterion in the literature is the >50% diameter stenosis at follow-up criterion. This criterion is historically based on the physiological concept of coronary flow reserve introduced by Gould and others17 in 1974 and is taken because it represents the approximate value in animals with normal coronary arteries at which blunting of the hyperemic response occurs. Although this criterion may be of some relevance in determining a clinically significant stenosis in human atherosclerotic vessels, it is a static measurement of lesion severity and tells us nothing about the dynamic behavior of the restenosis process. If the "50% diameter stenosis at follow-up" criterion is applied, lesions with a suboptimal angioplasty result will preferentially be selected (ie, will have to undergo a small loss in lumen diameter to be classified as restenosed). Bourassa et al18 have recognized this shortcoming and thus considered lesions with .50% diameter stenosis at follow-up that did not show a change of at least 10% at follow-up as not "restenosed."
The predictive accuracy of the multivariate model for restenosis according to the 50% diameter stenosis criterion was very poor (Fig 2) . If in addition a change in percent diameter stenosis of at least 13% (twice the long-term variability for percent diameter stenosis measurements) was required, then predictive accuracy of the model improved markedly, since lesions with a suboptimal angioplasty result no longer unduly influenced the restenosis rate. This requirement shifts the ROC curve to the left upper corner. A criterion that better reflects the dynamic behavior of the lesion after PTCA is the .0.72-mm loss in lumen diameter criterion as proposed by our group.5'8"2 This criterion is not meant to be a restenosis criterion strictu sensu, since that also implies some sort of functional measure of lesion severity at follow-up, but rather an indicator of significant intraluminal growth as monitored angiographically. Predictive Factors for Luminal Narrowing After Balloon Angioplasty If restenosis is viewed as an intraluminal growth process after a successful angioplasty, risk factors for restenosis should be risk factors for this growth process. Therefore, we determined risk factors for the absolute amount of quantitative angiographic luminal narrowing rather than for the crossing of a more or less arbitrary cut-off point (eg, 50% diameter stenosis or loss .0.72 mm).
A distinction should be made between lesions that progress toward total occlusion and lesions that remain patent at follow-up, since it is likely that part of the luminal narrowing observed in former lesions is caused by thrombosis and not only by the fibroproliferative process. The larger luminal narrowing in lesions in patients with diabetes, unstable angina, in totally occluded lesions, lesions with visible collateral circulation, and lesions with a visible thrombus after angioplasty was largely determined by a higher incidence of total occlusions at follow-up.
Patient-Related Factors
Diabetes, unstable angina, and duration of angina shorter than 2.3 months were associated with more luminal narrowing at follow-up. If total occlusions at follow-up were disregarded, none of these variables showed significantly more narrowing. In multivariate analysis however, diabetes was independently predictive of luminal narrowing.
The assumption that risk factors for the magnitude of the restenosis process are similar to risk factors for atherosclerosis was not confirmed in the present study. Only diabetes was found to be independently related to the amount of luminal narrowing at follow-up. This finding has also been recognized by others. [19] [20] [21] [22] [23] [24] [25] [26] In a recent study by Bourassa et al18 using the same quantitative angiographic analysis system, diabetes was not found to be predictive of restenosis. Other classic risk factors for atherosclerosis such as male sex, systemic hypertension, high cholesterol level, and continued smoking after the PTCA were not found to be related to luminal narrowing in the present study. The controversy regarding these risk factors is considerable, with many studies being positive for one or more patient-related factors and many studies being negative.2728
Lesion-Related Factors
Preangioplasty variables. In univariate analysis, five preangioplasty variables were associated with more luminal narrowing at follow-up: minimal lumen diameter before angioplasty, percent diameter stenosis before angioplasty, length of stenosis, total occlusion before angioplasty, and collateral circulation to dilatation site. A relation between stenosis severity and restenosis rate has been shown previously.18 '20'21'29 It is conceivable that more severe lesions undergo more severe vessel wall damage during the procedure, a known trigger for the hyperplastic reaction. [30] [31] [32] In our multivariate analysis, the preangioplasty minimal lumen diameter was found to be an independent determinant of subsequent loss in lumen diameter. In longer lesions, more smooth muscle is possibly exposed to injury and platelet adhesion, which probably enhances the intimal hyperplastic reaction.
A relation between stenosis length and the restenosis process has also been described by others.18'3334 Total occlusion before angioplasty is a well-known factor connected with total occlusion at follow-up35'36 and thus a large loss in lumen diameter at follow-up. Because total occlusion before angioplasty is part of the continuous-variables minimal lumen diameter and diameter stenosis before PTCA, total occlusion before angioplasty was not found to be an independent predictor of loss in lumen diameter.
Collateral circulation to the dilatation site will be more abundant in case of a severe stenosis or total occlusion. Since the severity of the lesion (minimal lumen diameter) before angioplasty was found to be an independent determinant for the absolute loss in lumen diameter at follow-up, the presence of collaterals was not retained in the model.
No differences in luminal narrowing was observed for the three coronary arteries. Others23,2837-39 have reported a higher incidence of restenosis for the left anterior descending artery, a finding recently challenged by Hermans et '23,29,37,42 In general, they applied the 50% diameter stenosis cut-off point and, as discussed above, lesions with a poor postangioplasty result will exceed this cut-off point with only minimal additional deterioration.
Because lesions with a low percent diameter stenosis and a large lumen diameter after angioplasty were also the lesions that underwent a high relative gain at angioplasty and since this variable was the strongest independent predictor of the absolute amount of luminal narrowing at follow-up, percent diameter stenosis after angioplasty and lumen diameter after angioplasty were not retained in the multivariate analysis.
Thrombus after angioplasty was retained in the multivariate model. Five of 16 lesions (31%) with a visible thrombus after angioplasty were totally occluded at follow-up and therefore showed a greater overall loss in lumen diameter.
We did not find an association between coronary dissection immediately after angioplasty and subsequent luminal renarrowing. Conflicting data have been reported concerning dissection and restenosis. 22, 23, [43] [44] [45] [46] However, it is clear that severe dissections are associated with a higher acute complication45 and restenosis rate, the latter probably due to a poorer angioplasty result in combination with the 50% diameter stenosis criterion.
Procedure-Related Variables
Balloon oversizing (balloon-artery ratio >1 However, the poor fit of the model even when tested in the same population underscores the poor predictability of the restenosis process.
The analyses described in this study were based on data from a restenosis prevention trial (CARPORT). That The variable most strongly associated with the amount of luminal narrowing at follow-up was the relative gain at angioplasty. It must be noted that lesions with a large gain at PTCA not only can but also will undergo a larger loss in lumen diameter at followup. Because drugs currently under development to prevent the restenosis process after balloon angioplasty are designed to reduce the absolute amount of intimal hyperplasia, the highest possible benefit of a new drug treatment might be expected in lesions with the characteristics retained in the present multivariate model.
